> top > docs > PMC:2674207 > spans > 38325-38840 > annotations

PMC:2674207 / 38325-38840 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T19790 0-3 DT denotes The
T19791 4-10 JJ denotes median
T19792 11-14 CC denotes and
T19793 15-28 JJ denotes interquartile
T19794 29-35 NN denotes ranges
T19795 36-39 IN denotes for
T19796 40-44 DT denotes each
T19797 45-54 NN denotes treatment
T19798 55-58 VB denotes are
T19799 59-68 VB denotes presented
T19800 69-71 IN denotes as
T19801 72-73 DT denotes a
T19802 74-90 NN denotes box-and-whiskers
T19803 91-95 NN denotes plot
T19804 96-97 -LRB- denotes (
T19805 97-102 NN denotes n = 7
T19806 102-103 -RRB- denotes )
T19807 103-104 -COLON- denotes ;
T19808 105-106 SYM denotes *
T19809 107-108 NN denotes p
T19810 108-109 SYM denotes <
T19811 109-113 CD denotes 0.05
T19812 114-122 NNP denotes Wilcoxon
T19813 122-124 POS denotes 's
T19814 125-129 NN denotes rank
T19815 130-134 NN denotes test
T19816 135-143 VB denotes compared
T19817 144-148 IN denotes with
T19818 149-157 NN denotes placebo.
T19819 158-159 -LRB- denotes (
T19820 159-160 NN denotes C
T19821 160-161 -RRB- denotes )
T19822 162-176 NN denotes Immunoblotting
T19823 177-185 NN denotes analyses
T19824 186-188 IN denotes of
T19825 189-194 NN denotes PBMCs
T19826 195-207 VB denotes demonstrated
T19827 208-209 DT denotes a
T19828 210-224 JJ denotes time-dependent
T19829 225-233 NN denotes decrease
T19830 234-236 IN denotes in
T19831 237-244 JJ denotes nuclear
T19832 245-255 NN denotes expression
T19833 256-258 IN denotes of
T19834 259-265 NN denotes GATA-3
T19835 265-266 -COMMA- denotes ,
T19836 267-270 CC denotes and
T19837 271-280 VB denotes increased
T19838 281-292 JJ denotes cytoplasmic
T19839 293-299 NN denotes GATA-3
T19840 300-310 NN denotes expression
T19841 311-316 IN denotes after
T19842 317-327 NN denotes inhalation
T19843 328-330 IN denotes of
T19844 331-334 NNP denotes FP.
T19845 335-336 -LRB- denotes (
T19846 336-337 NN denotes D
T19847 337-338 -RRB- denotes )
T19848 339-353 NN denotes Immunoblotting
T19849 354-362 NN denotes analyses
T19850 363-365 IN denotes of
T19851 366-371 NN denotes PBMCs
T19852 372-384 VB denotes demonstrated
T19853 385-386 DT denotes a
T19854 387-401 JJ denotes dose-dependent
T19855 402-410 NN denotes decrease
T19856 411-413 IN denotes in
T19857 414-421 JJ denotes nuclear
T19858 422-432 NN denotes expression
T19859 433-435 IN denotes of
T19860 436-442 NN denotes GATA-3
T19861 442-443 -COMMA- denotes ,
T19862 444-447 CC denotes and
T19863 448-457 VB denotes increased
T19864 458-469 JJ denotes cytoplasmic
T19865 470-476 NN denotes GATA-3
T19866 477-487 NN denotes expression
T19867 488-489 CD denotes 2
T19868 490-491 NN denotes h
T19869 492-497 IN denotes after
T19870 498-508 NN denotes inhalation
T19871 509-511 IN denotes of
T19872 512-514 NN denotes FP
R16894 T19791 T19792 arg1Of median,and
R16895 T19793 T19792 arg2Of interquartile,and
R16896 T19794 T19790 arg1Of ranges,The
R16897 T19794 T19791 arg1Of ranges,median
R16898 T19794 T19793 arg1Of ranges,interquartile
R16899 T19794 T19795 arg1Of ranges,for
R16900 T19794 T19798 arg1Of ranges,are
R16901 T19794 T19799 arg2Of ranges,presented
R16902 T19797 T19795 arg2Of treatment,for
R16903 T19797 T19796 arg1Of treatment,each
R16904 T19799 T19798 arg2Of presented,are
R16905 T19799 T19800 arg1Of presented,as
R16906 T19799 T19807 arg1Of presented,;
R16907 T19803 T19800 arg2Of plot,as
R16908 T19803 T19801 arg1Of plot,a
R16909 T19803 T19802 arg1Of plot,box-and-whiskers
R16910 T19803 T19804 arg1Of plot,(
R16911 T19805 T19804 arg2Of n = 7,(
R16912 T19806 T19804 arg3Of ),(
R16913 T19811 T19810 arg1Of 0.05,<
R16914 T19812 T19808 arg1Of Wilcoxon,*
R16915 T19812 T19809 arg1Of Wilcoxon,p
R16916 T19812 T19811 arg1Of Wilcoxon,0.05
R16917 T19812 T19813 arg2Of Wilcoxon,'s
R16918 T19815 T19813 arg1Of test,'s
R16919 T19815 T19814 arg1Of test,rank
R16920 T19815 T19816 arg1Of test,compared
R16921 T19815 T19826 arg1Of test,demonstrated
R16922 T19817 T19816 arg2Of with,compared
R16923 T19820 T19819 arg2Of C,(
R16924 T19821 T19819 arg3Of ),(
R16925 T19823 T19817 arg2Of analyses,with
R16926 T19823 T19818 arg1Of analyses,placebo.
R16927 T19823 T19819 arg1Of analyses,(
R16928 T19823 T19822 arg1Of analyses,Immunoblotting
R16929 T19823 T19824 arg1Of analyses,of
R16930 T19825 T19824 arg2Of PBMCs,of
R16931 T19826 T19836 arg1Of demonstrated,and
R16932 T19829 T19826 arg2Of decrease,demonstrated
R16933 T19829 T19827 arg1Of decrease,a
R16934 T19829 T19828 arg1Of decrease,time-dependent
R16935 T19829 T19830 arg1Of decrease,in
R16936 T19832 T19830 arg2Of expression,in
R16937 T19832 T19831 arg1Of expression,nuclear
R16938 T19832 T19833 arg1Of expression,of
R16939 T19834 T19833 arg2Of GATA-3,of
R16940 T19836 T19807 arg2Of and,;
R16941 T19836 T19835 arg1Of and,","
R16942 T19840 T19837 arg2Of expression,increased
R16943 T19840 T19838 arg1Of expression,cytoplasmic
R16944 T19840 T19839 arg1Of expression,GATA-3
R16945 T19840 T19841 arg1Of expression,after
R16946 T19840 T19852 arg1Of expression,demonstrated
R16947 T19840 T19863 arg1Of expression,increased
R16948 T19842 T19841 arg2Of inhalation,after
R16949 T19842 T19843 arg1Of inhalation,of
R16950 T19846 T19845 arg2Of D,(
R16951 T19847 T19845 arg3Of ),(
R16952 T19849 T19843 arg2Of analyses,of
R16953 T19849 T19844 arg1Of analyses,FP.
R16954 T19849 T19845 arg1Of analyses,(
R16955 T19849 T19848 arg1Of analyses,Immunoblotting
R16956 T19849 T19850 arg1Of analyses,of
R16957 T19851 T19850 arg2Of PBMCs,of
R16958 T19852 T19862 arg1Of demonstrated,and
R16959 T19855 T19852 arg2Of decrease,demonstrated
R16960 T19855 T19853 arg1Of decrease,a
R16961 T19855 T19854 arg1Of decrease,dose-dependent
R16962 T19855 T19856 arg1Of decrease,in
R16963 T19858 T19856 arg2Of expression,in
R16964 T19858 T19857 arg1Of expression,nuclear
R16965 T19858 T19859 arg1Of expression,of
R16966 T19860 T19859 arg2Of GATA-3,of
R16967 T19862 T19836 arg2Of and,and
R16968 T19862 T19861 arg1Of and,","
R16969 T19863 T19862 arg2Of increased,and
R16970 T19863 T19869 arg1Of increased,after
R16971 T19866 T19863 arg2Of expression,increased
R16972 T19866 T19864 arg1Of expression,cytoplasmic
R16973 T19866 T19865 arg1Of expression,GATA-3
R16974 T19868 T19867 arg1Of h,2
R16975 T19869 T19868 arg1Of after,h
R16976 T19870 T19869 arg2Of inhalation,after
R16977 T19870 T19871 arg1Of inhalation,of
R16978 T19872 T19871 arg2Of FP,of

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T20044 0-3 DT denotes The
T20045 4-10 NN denotes median
T20046 11-14 CC denotes and
T20047 15-28 JJ denotes interquartile
T20048 29-35 NNS denotes ranges
T20049 36-39 IN denotes for
T20050 40-44 DT denotes each
T20051 45-54 NN denotes treatment
T20052 55-58 VBP denotes are
T20053 59-68 VBN denotes presented
T20054 69-71 IN denotes as
T20055 72-73 DT denotes a
T20056 74-90 NNS denotes box-and-whiskers
T20057 91-95 NN denotes plot
T20058 96-97 -LRB- denotes (
T20059 97-98 FW denotes n
T20060 99-100 SYM denotes =
T20061 101-102 CD denotes 7
T20062 102-103 -RRB- denotes )
T20063 103-104 : denotes ;
T20064 105-106 SYM denotes *
T20065 107-108 NN denotes p
T20066 108-109 NN denotes <
T20067 109-113 CD denotes 0.05
T20068 114-122 NNP denotes Wilcoxon
T20069 122-124 POS denotes 's
T20070 125-129 NN denotes rank
T20071 130-134 NN denotes test
T20072 135-143 VBN denotes compared
T20073 144-148 IN denotes with
T20074 149-156 NN denotes placebo
T20075 156-157 . denotes .
T20076 158-159 -LRB- denotes (
T20077 159-160 NNP denotes C
T20078 160-161 -RRB- denotes )
T20079 162-176 NNP denotes Immunoblotting
T20080 177-185 NNS denotes analyses
T20081 186-188 IN denotes of
T20082 189-194 NNP denotes PBMCs
T20083 195-207 VBD denotes demonstrated
T20084 208-209 DT denotes a
T20085 210-224 JJ denotes time-dependent
T20086 225-233 NN denotes decrease
T20087 234-236 IN denotes in
T20088 237-244 JJ denotes nuclear
T20089 245-255 NN denotes expression
T20090 256-258 IN denotes of
T20091 259-265 NNP denotes GATA-3
T20092 265-266 , denotes ,
T20093 267-270 CC denotes and
T20094 271-280 VBD denotes increased
T20095 281-292 JJ denotes cytoplasmic
T20096 293-299 JJ denotes GATA-3
T20097 300-310 NN denotes expression
T20098 311-316 IN denotes after
T20099 317-327 NN denotes inhalation
T20100 328-330 IN denotes of
T20101 331-333 NNP denotes FP
T20102 333-334 . denotes .
T20103 335-336 -LRB- denotes (
T20104 336-337 NNP denotes D
T20105 337-338 -RRB- denotes )
T20106 339-353 NNP denotes Immunoblotting
T20107 354-362 NNS denotes analyses
T20108 363-365 IN denotes of
T20109 366-371 NNP denotes PBMCs
T20110 372-384 VBD denotes demonstrated
T20111 385-386 DT denotes a
T20112 387-401 JJ denotes dose-dependent
T20113 402-410 NN denotes decrease
T20114 411-413 IN denotes in
T20115 414-421 JJ denotes nuclear
T20116 422-432 NN denotes expression
T20117 433-435 IN denotes of
T20118 436-442 NNP denotes GATA-3
T20119 442-443 , denotes ,
T20120 444-447 CC denotes and
T20121 448-457 VBD denotes increased
T20122 458-469 JJ denotes cytoplasmic
T20123 470-476 JJ denotes GATA-3
T20124 477-487 NN denotes expression
T20125 488-489 CD denotes 2
T20126 490-491 NN denotes h
T20127 492-497 IN denotes after
T20128 498-508 NN denotes inhalation
T20129 509-511 IN denotes of
T20130 512-514 NNP denotes FP
T20131 514-515 . denotes .
R17137 T20044 T20048 det The,ranges
R17138 T20045 T20048 amod median,ranges
R17139 T20046 T20045 cc and,median
R17140 T20047 T20045 conj interquartile,median
R17141 T20048 T20053 nsubjpass ranges,presented
R17142 T20049 T20048 prep for,ranges
R17143 T20050 T20051 det each,treatment
R17144 T20051 T20049 pobj treatment,for
R17145 T20052 T20053 auxpass are,presented
R17146 T20053 T20053 ROOT presented,presented
R17147 T20054 T20053 prep as,presented
R17148 T20055 T20057 det a,plot
R17149 T20056 T20057 compound box-and-whiskers,plot
R17150 T20057 T20054 pobj plot,as
R17151 T20058 T20061 punct (,7
R17152 T20059 T20061 advmod n,7
R17153 T20060 T20061 punct =,7
R17154 T20061 T20057 appos 7,plot
R17155 T20062 T20061 punct ),7
R17156 T20063 T20053 punct ;,presented
R17200 T20107 T20110 nsubj analyses,demonstrated
R17201 T20108 T20107 prep of,analyses
R17202 T20109 T20108 pobj PBMCs,of
R17203 T20110 T20110 ROOT demonstrated,demonstrated
R17204 T20111 T20113 det a,decrease
R17205 T20112 T20113 amod dose-dependent,decrease
R17206 T20113 T20110 dobj decrease,demonstrated
R17207 T20114 T20113 prep in,decrease
R17208 T20115 T20116 amod nuclear,expression
R17209 T20116 T20114 pobj expression,in
R17210 T20117 T20116 prep of,expression
R17211 T20118 T20117 pobj GATA-3,of
R17212 T20119 T20110 punct ",",demonstrated
R17213 T20120 T20110 cc and,demonstrated
R17214 T20121 T20110 conj increased,demonstrated
R17215 T20122 T20124 amod cytoplasmic,expression
R17216 T20123 T20124 amod GATA-3,expression
R17217 T20124 T20121 dobj expression,increased
R17218 T20125 T20126 nummod 2,h
R17219 T20126 T20124 appos h,expression
R17220 T20127 T20126 prep after,h
R17221 T20128 T20127 pobj inhalation,after
R17222 T20129 T20128 prep of,inhalation
R17223 T20130 T20129 pobj FP,of
R17224 T20131 T20110 punct .,demonstrated
R17157 T20064 T20066 punct *,<
R17158 T20065 T20066 compound p,<
R17159 T20066 T20053 conj <,presented
R17160 T20067 T20071 nummod 0.05,test
R17161 T20068 T20071 poss Wilcoxon,test
R17162 T20069 T20068 case 's,Wilcoxon
R17163 T20070 T20071 compound rank,test
R17164 T20071 T20066 appos test,<
R17165 T20072 T20071 prep compared,test
R17166 T20073 T20072 prep with,compared
R17167 T20074 T20073 pobj placebo,with
R17168 T20075 T20053 punct .,presented
R17169 T20076 T20080 punct (,analyses
R17170 T20077 T20080 compound C,analyses
R17171 T20078 T20079 punct ),Immunoblotting
R17172 T20079 T20080 compound Immunoblotting,analyses
R17173 T20080 T20083 nsubj analyses,demonstrated
R17174 T20081 T20080 prep of,analyses
R17175 T20082 T20081 pobj PBMCs,of
R17176 T20083 T20083 ROOT demonstrated,demonstrated
R17177 T20084 T20086 det a,decrease
R17178 T20085 T20086 amod time-dependent,decrease
R17179 T20086 T20083 dobj decrease,demonstrated
R17180 T20087 T20086 prep in,decrease
R17181 T20088 T20089 amod nuclear,expression
R17182 T20089 T20087 pobj expression,in
R17183 T20090 T20089 prep of,expression
R17184 T20091 T20090 pobj GATA-3,of
R17185 T20092 T20083 punct ",",demonstrated
R17186 T20093 T20083 cc and,demonstrated
R17187 T20094 T20097 amod increased,expression
R17188 T20095 T20097 amod cytoplasmic,expression
R17189 T20096 T20097 amod GATA-3,expression
R17190 T20097 T20083 conj expression,demonstrated
R17191 T20098 T20097 prep after,expression
R17192 T20099 T20098 pobj inhalation,after
R17193 T20100 T20099 prep of,inhalation
R17194 T20101 T20100 pobj FP,of
R17195 T20102 T20083 punct .,demonstrated
R17196 T20103 T20110 punct (,demonstrated
R17197 T20104 T20107 compound D,analyses
R17198 T20105 T20106 punct ),Immunoblotting
R17199 T20106 T20107 compound Immunoblotting,analyses

sentences

Id Subject Object Predicate Lexical cue
T19728 0-515 Sentence denotes The median and interquartile ranges for each treatment are presented as a box-and-whiskers plot (n = 7); * p<0.05 Wilcoxon's rank test compared with placebo. (C) Immunoblotting analyses of PBMCs demonstrated a time-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression after inhalation of FP. (D) Immunoblotting analyses of PBMCs demonstrated a dose-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression 2 h after inhalation of FP.
T254 0-515 Sentence denotes The median and interquartile ranges for each treatment are presented as a box-and-whiskers plot (n = 7); * p<0.05 Wilcoxon's rank test compared with placebo. (C) Immunoblotting analyses of PBMCs demonstrated a time-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression after inhalation of FP. (D) Immunoblotting analyses of PBMCs demonstrated a dose-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression 2 h after inhalation of FP.

events-check-again

Id Subject Object Predicate Lexical cue
T20342 215-224 Regulation denotes dependent
T20343 215-224 Regulation denotes dependent
T20344 225-233 Negative_regulation denotes decrease
T20345 237-244 Entity denotes nuclear
T20346 245-255 Localization denotes expression
T20347 259-265 Protein denotes GATA-3
T20348 271-280 Positive_regulation denotes increased
T20349 281-292 Entity denotes cytoplasmic
T20350 293-299 Protein denotes GATA-3
T20351 300-310 Localization denotes expression
T20352 402-410 Negative_regulation denotes decrease
T20353 414-421 Entity denotes nuclear
T20354 422-432 Localization denotes expression
T20355 436-442 Protein denotes GATA-3
T20356 458-469 Entity denotes cytoplasmic
T20357 470-476 Protein denotes GATA-3
T20358 477-487 Localization denotes expression
R17391 T20344 T20342 themeOf decrease,dependent
R17392 T20345 T20346 locationOf nuclear,expression
R17393 T20346 T20344 themeOf expression,decrease
R17394 T20347 T20346 themeOf GATA-3,expression
R17395 T20348 T20343 themeOf increased,dependent
R17396 T20349 T20351 locationOf cytoplasmic,expression
R17397 T20350 T20351 themeOf GATA-3,expression
R17398 T20351 T20348 themeOf expression,increased
R17399 T20353 T20354 locationOf nuclear,expression
R17400 T20354 T20352 themeOf expression,decrease
R17401 T20355 T20354 themeOf GATA-3,expression
R17402 T20356 T20358 locationOf cytoplasmic,expression
R17403 T20357 T20358 themeOf GATA-3,expression

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T20311 259-265 Protein denotes GATA-3
T20312 281-299 Protein denotes cytoplasmic GATA-3
T20313 331-333 Protein denotes FP
T20314 237-244 Entity denotes nuclear
T20315 245-255 Gene_expression denotes expression
T20316 300-310 Gene_expression denotes expression
T20317 317-327 Negative_regulation denotes inhalation
T20318 225-233 Negative_regulation denotes decrease
T20319 225-233 Negative_regulation denotes decrease
T20320 271-280 Positive_regulation denotes increased
T20321 436-442 Protein denotes GATA-3
T20322 512-514 Protein denotes FP
T20323 414-421 Entity denotes nuclear
T20324 422-432 Gene_expression denotes expression
T20325 402-410 Negative_regulation denotes decrease
R17370 T20311 T20315 themeOf GATA-3,expression
R17371 T20312 T20316 themeOf cytoplasmic GATA-3,expression
R17372 T20313 T20317 themeOf FP,inhalation
R17373 T20315 T20318 themeOf expression,decrease
R17374 T20316 T20319 themeOf expression,decrease
R17375 T20316 T20320 themeOf expression,increased
R17376 T20317 T20318 causeOf inhalation,decrease
R17377 T20317 T20319 causeOf inhalation,decrease
R17378 T20321 T20324 themeOf GATA-3,expression
R17379 T20324 T20325 themeOf expression,decrease

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T19708 215-224 Regulation denotes dependent
T19709 215-224 Regulation denotes dependent
T19710 225-233 Negative_regulation denotes decrease
T19711 237-244 Entity denotes nuclear
T19712 245-255 Localization denotes expression
T19713 259-265 Protein denotes GATA-3
T19714 271-280 Positive_regulation denotes increased
T19715 281-292 Entity denotes cytoplasmic
T19716 293-299 Protein denotes GATA-3
T19717 300-310 Localization denotes expression
T19718 402-410 Negative_regulation denotes decrease
T19719 414-421 Entity denotes nuclear
T19720 422-432 Localization denotes expression
T19721 436-442 Protein denotes GATA-3
T19722 458-469 Entity denotes cytoplasmic
T19723 470-476 Protein denotes GATA-3
T19724 477-487 Localization denotes expression
R16823 T19710 T19708 themeOf decrease,dependent
R16824 T19711 T19712 locationOf nuclear,expression
R16825 T19712 T19710 themeOf expression,decrease
R16826 T19713 T19712 themeOf GATA-3,expression
R16827 T19714 T19709 themeOf increased,dependent
R16828 T19715 T19717 locationOf cytoplasmic,expression
R16829 T19716 T19717 themeOf GATA-3,expression
R16830 T19717 T19714 themeOf expression,increased
R16831 T19719 T19720 locationOf nuclear,expression
R16832 T19720 T19718 themeOf expression,decrease
R16833 T19721 T19720 themeOf GATA-3,expression
R16834 T19722 T19724 locationOf cytoplasmic,expression
R16835 T19723 T19724 themeOf GATA-3,expression

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T19974 259-265 P23771 denotes GATA-3
T19975 293-299 P23771 denotes GATA-3
T19976 436-442 P23771 denotes GATA-3
T19977 470-476 P23771 denotes GATA-3

test2

Id Subject Object Predicate Lexical cue
T19679 215-224 Regulation denotes dependent
T19680 225-233 Negative_regulation denotes decrease
T19681 237-244 Entity denotes nuclear
T19682 245-255 Gene_expression denotes expression
T19683 259-265 Protein denotes GATA-3
T19684 271-280 Positive_regulation denotes increased
T19685 281-292 Entity denotes cytoplasmic
T19686 293-299 Protein denotes GATA-3
T19687 300-310 Gene_expression denotes expression
T19688 392-401 Regulation denotes dependent
T19689 402-410 Negative_regulation denotes decrease
T19690 414-421 Entity denotes nuclear
T19691 422-432 Gene_expression denotes expression
T19692 436-442 Protein denotes GATA-3
T19693 448-457 Positive_regulation denotes increased
T19694 458-469 Entity denotes cytoplasmic
T19695 470-476 Protein denotes GATA-3
T19696 477-487 Gene_expression denotes expression
R16804 T19681 T19682 locationOf nuclear,expression
R16809 T19687 T19684 themeOf expression,increased
R16805 T19682 T19680 themeOf expression,decrease
R16806 T19683 T19682 themeOf GATA-3,expression
R16807 T19685 T19687 locationOf cytoplasmic,expression
R16808 T19686 T19687 themeOf GATA-3,expression
R16810 T19690 T19691 locationOf nuclear,expression
R16811 T19691 T19689 themeOf expression,decrease
R16812 T19692 T19691 themeOf GATA-3,expression
R16813 T19694 T19696 locationOf cytoplasmic,expression
R16814 T19695 T19696 themeOf GATA-3,expression
R16815 T19696 T19693 themeOf expression,increased